Skip to main content

Advertisement

Log in

T2*-weighted MR imaging findings of giant cell tumors of bone: radiological–pathological correlation

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

To assess the correlation between T2*-weighted MR imaging and pathological findings of giant cell tumors (GCT) of bone.

Methods

Of the 33 patients with histopathologically proven GCT of bone, 12 were examined using 1.5-T MR imaging, including T2*-weighted imaging, and were included in this study. The imaging and pathological findings of GCTs were compared between GCTs with and without hypointensity on T2*-weighted images (T2* hypointensity).

Results

T2* hypointensity was observed in 6 out of 12 (50%) GCTs. Septal formation (83% vs. 17%; p < 0.05) and cystic formation (67% vs. 0%; p < 0.05) on T2-weighted images was significantly more frequent in the GCTs with T2* hypointensity compared with those without T2* hypointensity. Among the six GCTs with T2* hypointensity, a large amount of hemosiderin deposition was pathologically observed in five (83%) cases, whereas small amounts of hemosiderin deposition was seen in one (17%) case. In contrast, among the six GCTs without T2* hypointensity, a small amount of hemosiderin deposition was pathologically observed in all six (100%).

Conclusion

Half of the GCTs showed T2* hypointensity, which is characteristic of hemosiderin deposition; whereas, the other half did not show T2* hypointensity due to a small amount of hemosiderin deposition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sobti A, Agrawal P, Agarwala S, Agarwal M. Giant cell tumor of bone—an overview. Arch Bone Jt Surg. 2016;4(1):2–9.

    PubMed  PubMed Central  Google Scholar 

  2. Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GR Jr. Giant cell tumor of bone: review, mimics, and new developments in treatment. Radiographics. 2013;33(1):197–211.

    Article  PubMed  Google Scholar 

  3. Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics. 2001;21(5):1283–309.

    Article  CAS  PubMed  Google Scholar 

  4. Stacy GS, Peabody TD, Dixon LB. Mimics on radiography of giant cell tumor of bone. AJR Am J Roentgenol. 2003;181(6):1583–9.

    Article  PubMed  Google Scholar 

  5. Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, Panagopoulos GN, Papagelopoulos PJ, Soucacos PN. Giant cell tumor of bone revisited. SICOT J. 2017;3:54.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bridge JA, Neff JR, Mouron BJ. Giant cell tumor of bone: chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet. 1992;58(1):2–13.

    Article  CAS  PubMed  Google Scholar 

  7. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20(4):637–42.

    CAS  PubMed  Google Scholar 

  8. Tsushima Y, Aoki J, Endo K. Brain microhemorrhages detected on T2*-weighted gradient-echo MR images. AJNR Am J Neuroradiol. 2003;24(1):88–96.

    PubMed  Google Scholar 

  9. Shams S, Martola J, Cavallin L, Granberg T, Shams M, Aspelin P, et al. SWI or T2*: which MRI sequence to use in the detection of cerebral microbleeds? The Karolinska Imaging Dementia Study. AJNR Am J Neuroradiol. 2015;36(6):1089–95.

    Article  CAS  PubMed  Google Scholar 

  10. Aoki J, Moriya K, Yamashita K, Fujioka F, Ishii K, Karakida O, et al. Giant cell tumors of bone containing large amounts of hemosiderin: MR-pathologic correlation. J Comput Assist Tomogr. 1991;15(6):1024–7.

    Article  CAS  PubMed  Google Scholar 

  11. Aoki J, Tanikawa H, Ishii K, Seo GS, Karakida O, Sone S, et al. MR findings indicative of hemosiderin in giant-cell tumor of bone: frequency, cause, and diagnostic significance. AJR Am J Roentgenol. 1996;166(1):145–8.

    Article  CAS  PubMed  Google Scholar 

  12. Purohit S, Pardiwala DN. Imaging of giant cell tumor of bone. Indian J Orthop. 2007;41(2):91–6.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lee MJ, Sallomi DF, Munk PL, Janzen DL, Connell DG, O’Connell JX, et al. Pictorial review: giant cell tumours of bone. Clin Radiol. 1998;53(7):481–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors declare that there is no funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroki Kato.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

The authors declare that they preserve ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishibori, H., Kato, H., Kawaguchi, M. et al. T2*-weighted MR imaging findings of giant cell tumors of bone: radiological–pathological correlation. Jpn J Radiol 37, 473–480 (2019). https://doi.org/10.1007/s11604-019-00829-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-019-00829-z

Keywords

Navigation